Integer Holdings Corporation (NYSE:ITGR) Receives Average Recommendation of “Hold” from Analysts

Shares of Integer Holdings Corporation (NYSE:ITGR) have been given an average recommendation of “Hold” by the eleven brokerages that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, six have given a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $98.7143.

ITGR has been the topic of several recent analyst reports. Zacks Research downgraded shares of Integer from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Citigroup lifted their price objective on Integer from $89.00 to $92.00 and gave the company a “neutral” rating in a research note on Thursday, May 28th. Piper Sandler reiterated an “overweight” rating and set a $97.00 price target (up from $87.00) on shares of Integer in a report on Friday, May 1st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th.

Integer Trading Down 3.1%

Shares of NYSE:ITGR opened at $90.98 on Tuesday. The business’s fifty day simple moving average is $89.35 and its 200-day simple moving average is $85.78. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77. Integer has a 12-month low of $62.00 and a 12-month high of $123.49. The company has a market capitalization of $3.09 billion, a PE ratio of 22.69, a P/E/G ratio of 2.24 and a beta of 0.66.

Integer (NYSE:ITGR) last released its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). The company had revenue of $439.58 million for the quarter, compared to analysts’ expectations of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities research analysts predict that Integer will post 6.04 earnings per share for the current fiscal year.

Institutional Trading of Integer

Several hedge funds and other institutional investors have recently made changes to their positions in ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Integer by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock valued at $2,539,000 after purchasing an additional 837 shares during the period. Millennium Management LLC raised its holdings in shares of Integer by 2,408.8% in the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after acquiring an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp raised its position in shares of Integer by 79,888.9% in the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock valued at $850,000 after buying an additional 7,190 shares during the last quarter. United Services Automobile Association acquired a new position in shares of Integer in the first quarter valued at approximately $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Integer by 4.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock valued at $12,900,000 after purchasing an additional 4,873 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.